NCT00437164View on ClinicalTrials.gov

A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus

PHASE2TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Type 2 Diabetes MellitusDiabetes Mellitus, Type 2

Interventions

DRUG

Insulin

DRUG

Oral GW677954 Capsules (15 mg)

Trial Locations (1)

90211

GSK Investigational Site, Beverly Hills

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00437164 - A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter